Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
CBIO
Shares outstanding
13,888,889 shares
Disclosed Ownership
700,000 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
09 Oct 2025, 16:15:11 UTC
Date of event
02 Oct 2025
Next filing
15 May 2026

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 5% ownership in Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO) on 02 Oct 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO).
  • Disclosed ownership: 5%.
  • Date of event: 02 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 09 Oct 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 5% 700,000 0 700,000 /s/ Kevin Tang Manager
KEVIN TANG 5% 700,000 0 700,000 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 2.8% 393,681 0 393,681 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2.2% 306,319 0 306,319 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .